ARCC dividend yield: 9.06%. JNJ dividend yield: 3.36%. Ares Capital is the largest Business Development Company by assets. It provides financing to middle market companies and pays a generous quarterly dividend plus occasional special dividends. With $21B+ in AUM and diversified exposure across industries, ARCC is the benchmark BDC for income investors. Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.
Ares Capital is the largest Business Development Company by assets. It provides financing to middle market companies and pays a generous quarterly dividend plus occasional special dividends. With $21B+ in AUM and diversified exposure across industries, ARCC is the benchmark BDC for income investors.
Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.
Is ARCC or JNJ better for dividend income in 2026?
ARCC currently offers a 9.06% yield (1.92/share/year) while JNJ offers 3.36% (4.96/share/year). ARCC provides higher current income. However, JNJ has grown its dividend faster (5.8% 5Y CAGR), which may lead to better long-term income through compounding.
How much would $10,000 in ARCC vs JNJ earn per year?
With $10,000 invested today: ARCC pays approximately $906/year. JNJ pays approximately $336/year. With DRIP reinvestment over 10 years, these grow to $2,279/year (ARCC) and $828/year (JNJ).
Does ARCC or JNJ pay monthly dividends?
ARCC pays quarterly dividends. JNJ pays quarterly dividends. Neither pay monthly — both use a quarterly schedule, which is preferred by investors who need regular cash flow.
📬
Get this ARCC vs JNJ comparison by email
Save your analysis + get weekly dividend insights. Free forever.